Peng Lu
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Peng Lu currently works at Pharvaris NV, as Chief Medical Officer & Head-Research & Technology from 2024.
Dr. Lu also formerly worked at Takeda Nederland BV, as Vice President.
Dr. Lu received her doctorate degree from Beijing Medical University and doctorate degree from the University of Texas at Austin Graduate School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PHARVARIS N.V. 0,09% | 18-06-2026 | 65.631 ( 0,09% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARVARIS N.V. | Hoofd Techniek/Wetenschap/O&O | 07-02-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
Takeda Nederland BV
Takeda Nederland BV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Beijing Medical University
Beijing Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Nederland BV
Takeda Nederland BV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Pharvaris NV
Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
University of Texas at Austin Graduate School
University of Texas at Austin Graduate School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau